Goldman Sachs’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.3M Buy
725,822
+294,846
+68% +$11M ﹤0.01% 2083
2025
Q4
$15M Buy
430,976
+41,890
+11% +$3.29M ﹤0.01% 2660
2025
Q3
$32.3M Sell
389,086
-171,583
-31% -$12.4M ﹤0.01% 1797
2025
Q2
$41.2M Buy
560,669
+55,322
+11% +$4.01M 0.01% 1483
2025
Q1
$57.7M Sell
505,347
-120,899
-19% -$7.36M 0.01% 1138
2024
Q4
$31.6M Buy
626,246
+153,225
+32% +$8.03M 0.01% 1700
2024
Q3
$21.9M Sell
473,021
-5,553
-1% -$197K ﹤0.01% 1986
2024
Q2
$15.5M Buy
478,574
+43,852
+10% +$1.2M ﹤0.01% 2089
2024
Q1
$11M Sell
434,722
-98,038
-18% -$2.32M ﹤0.01% 2385
2023
Q4
$17.3M Buy
532,760
+124,185
+30% +$3.41M ﹤0.01% 2035
2023
Q3
$11.1M Buy
408,575
+45,308
+12% +$1.31M ﹤0.01% 2300
2023
Q2
$8.08M Sell
363,267
-40,164
-10% -$924K ﹤0.01% 2657
2023
Q1
$8.74M Sell
403,431
-70,770
-15% -$1.55M ﹤0.01% 2544
2022
Q4
$9.63M Buy
474,201
+52,208
+12% +$1.31M ﹤0.01% 2620
2022
Q3
$10.8M Buy
421,993
+113,353
+37% +$3.03M ﹤0.01% 2434
2022
Q2
$7.34M Sell
308,640
-39,946
-11% -$870K ﹤0.01% 2790
2022
Q1
$7.85M Sell
348,586
-2,760
-0.8% -$58.7K ﹤0.01% 2934
2021
Q4
$6.96M Sell
351,346
-207,637
-37% -$4.21M ﹤0.01% 3105
2021
Q3
$11M Buy
558,983
+165,748
+42% +$3.47M ﹤0.01% 2629
2021
Q2
$8.65M Sell
393,235
-90,781
-19% -$2.02M ﹤0.01% 2831
2021
Q1
$11.5M Sell
484,016
-48,457
-9% -$1.29M ﹤0.01% 2439
2020
Q4
$13.9M Buy
532,473
+55,759
+12% +$1.17M ﹤0.01% 2174
2020
Q3
$8.3M Sell
476,714
-483,997
-50% -$7.71M ﹤0.01% 2481
2020
Q2
$16.2M Buy
960,711
+98,581
+11% +$1.38M 0.01% 1856
2020
Q1
$10.3M Buy
862,130
+398,019
+86% +$4.93M ﹤0.01% 2068
2019
Q4
$5.62M Buy
464,111
+181,786
+64% +$2.53M ﹤0.01% 2873
2019
Q3
$3.99M Buy
282,325
+68,355
+32% +$840K ﹤0.01% 3035
2019
Q2
$2.39M Sell
213,970
-335,867
-61% -$3.74M ﹤0.01% 3417
2019
Q1
$6.46M Sell
549,837
-29,794
-5% -$370K ﹤0.01% 2770
2018
Q4
$7.74M Buy
579,631
+5,231
+0.9% +$69.1K ﹤0.01% 2529
2018
Q3
$8.05M Sell
574,400
-264,977
-32% -$3.7M ﹤0.01% 2618
2018
Q2
$13.2M Buy
839,377
+272,775
+48% +$4.75M ﹤0.01% 2203
2018
Q1
$9.32M Sell
566,602
-110,630
-16% -$2.05M ﹤0.01% 2383
2017
Q4
$12.2M Buy
677,232
+45,669
+7% +$827K ﹤0.01% 2302
2017
Q3
$12.2M Buy
631,563
+358,748
+131% +$5.35M ﹤0.01% 2399
2017
Q2
$3.22M Buy
272,815
+57,523
+27% +$625K ﹤0.01% 3431
2017
Q1
$2.36M Buy
215,292
+83,026
+63% +$729K ﹤0.01% 3585
2016
Q4
$960K Buy
132,266
+7,473
+6% +$58.6K ﹤0.01% 4494
2016
Q3
$811K Buy
124,793
+64,074
+106% +$373K ﹤0.01% 4609
2016
Q2
$332K Buy
60,719
+9,765
+19% +$50.8K ﹤0.01% 5247
2016
Q1
$238K Buy
50,954
+1,777
+4% +$6.92K ﹤0.01% 5464
2015
Q4
$244K Buy
49,177
+21,023
+75% +$94.8K ﹤0.01% 5534
2015
Q3
$106K Sell
28,154
-6,915
-20% -$35.1K ﹤0.01% 6445
2015
Q2
$211K Buy
+35,069
New +$215K ﹤0.01% 6102
2014
Q3
Sell
-163,159
Closed -$457K 7130
2014
Q2
$457K Buy
163,159
+135,442
+489% +$400K ﹤0.01% 5399
2014
Q1
$121K Buy
27,717
+5,942
+27% +$20.8K ﹤0.01% 6329
2013
Q4
$70K Buy
21,775
+6,425
+42% +$13K ﹤0.01% 6362
2013
Q3
$24K Buy
+15,350
New +$27.1K ﹤0.01% 6406

Other funds holding CORT